The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Nick Giannoukakis

University of Pittsburgh School of Medicine

Department of Pathology and Immunology

Diabetes Institute

Rangos Research Center



Name/email consistency: high



  • University of Pittsburgh School of Medicine, Department of Pathology and Immunology, Diabetes Institute, Rangos Research Center, USA. 2003 - 2008
  • Department of Pathology, University of Pittsburgh School of Medicine, PA 15213, USA. 2002 - 2005


  1. Ranirestat as a therapeutic aldose reductase inhibitor for diabetic complications. Giannoukakis, N. Expert. Opin. Investig. Drugs (2008) [Pubmed]
  2. BIM-51077, a dipeptidyl peptidase-IV-resistant glucagon-like peptide-1 analog. Giannoukakis, N. Curr. Opin. Investig. Drugs (2007) [Pubmed]
  3. Drug evaluation: ranirestat--an aldose reductase inhibitor for the potential treatment of diabetic complications. Giannoukakis, N. Curr. Opin. Investig. Drugs (2006) [Pubmed]
  4. Pyridoxamine (BioStratum). Giannoukakis, N. Curr. Opin. Investig. Drugs (2005) [Pubmed]
  5. Gene therapy for type 1 diabetes: a proposal to move to the next level. Giannoukakis, N., Trucco, M. Curr. Opin. Mol. Ther. (2005) [Pubmed]
  6. DiaPep277 (DeveloGen). Giannoukakis, N. Curr. Opin. Investig. Drugs (2005) [Pubmed]
  7. Exenatide. Amylin/Eli Lilly. Giannoukakis, N. Curr. Opin. Investig. Drugs (2003) [Pubmed]
  8. Fidarestat. Sanwa Kagaku/NC Curex/Sankyo. Giannoukakis, N. Curr. Opin. Investig. Drugs (2003) [Pubmed]
  9. CJC-1131. ConjuChem. Giannoukakis, N. Curr. Opin. Investig. Drugs (2003) [Pubmed]
  10. Genes and engineered cells as drugs for type I and type II diabetes mellitus therapy and prevention. Giannoukakis, N., Pietropaolo, M., Trucco, M. Curr. Opin. Investig. Drugs (2002) [Pubmed]
  11. Gene and cell therapies for diabetes mellitus: strategies and clinical potential. Giannoukakis, N., Robbins, P.D. BioDrugs (2002) [Pubmed]
  12. Therapeutic strategies for Type 1 and Type 2 diabetes mellitus. Giannoukakis, N., Pietropaolo, M., Trucco, M. Diabetes Nutr. Metab. (2002) [Pubmed]
  13. NBI-6024 (Neurocrine Biosciences). Giannoukakis, N. IDrugs (2002) [Pubmed]
WikiGenes - Universities